Clincosm LogoSign in Get a demo

cin2

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)

Recruiting
  • Cervix Uteri SIL
  • +3 more
  • Colposcopy
  • Prague, Czechia
    General University Hospital
Nov 24, 2023

Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • 5 Fluorouracil (5 FU) Cream
  • Placebo
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

Cervical Cancer, CIN2, CIN3 Trial in Westdene (Urine HPV testing, Self-collected cervicovaginal specimen, Provider-collected

Not yet recruiting
  • Cervical Cancer
  • +2 more
  • Urine HPV testing
  • +2 more
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Sep 14, 2022

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

Completed
  • HPV Infections
  • +14 more
  • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Active Comparator: GARDASIL ®9
  • Guangxi, China
    Guangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    Cervical Cancer Screening With Human Papillomavirus Testing

    Recruiting
    • CIN3
    • +2 more
    • HPV screening
    • Buenos Aires, Argentina
    • +11 more
    Apr 1, 2022

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

    Recruiting
    • HPV Infections
    • +14 more
    • 9-valent HPV vaccine
    • Hangzhou, China
      Huakun Lv
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

    Completed
    • Cervical Cancer
    • +13 more
    • 4-valent HPV Vaccine
    • +2 more
    • Yangchun, Guangdong, China
      Yangchun Center For Disease Prevention And Control
    Feb 23, 2022

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

    Recruiting
    • Cervical Cancer
    • +13 more
    • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
    • GARDASIL®
    • Rongan County, Guangxi Zhuang Autonomous Region, China
      Rongan County Center for Disease Control and Prevention
    Feb 20, 2022

    Cervical Cancer, High Grade Sil, CIN2 Trial in Pretoria (Screening, Colposcopy, LLETZ)

    Completed
    • Cervical Cancer
    • +2 more
    • Screening
    • +2 more
    • Pretoria, Gauteng, South Africa
      Steve Biko Academic Hospital
    Sep 23, 2021

    Human Papilloma Virus, Dysplasia, CIN1 Trial in Houston (AHCC 3 grams once a day, Placebo)

    Completed
    • Human Papilloma Virus
    • +3 more
    • AHCC 3 grams once a day
    • Placebo
    • Houston, Texas
      UTHealth Medical School at Houston
    Jan 15, 2021

    Cervical Cancers, Vulvar Cancer, Vaginal Cancer Trial in Hanzhou (9-valent HPV Recombinant Vaccine, Placebo)

    Completed
    • Cervical Cancers
    • +14 more
    • 9-valent HPV Recombinant Vaccine
    • Placebo
    • Hanzhou, China
      Zhejiang Provincial Center for Disease Control and Prevention
    Jan 20, 2020

    CIN2, Therapy Trial in Sweden (Expectancy)

    Unknown status
    • CIN2
    • Therapy
    • Expectancy
    • Borås, Sweden
    • +4 more
    Apr 3, 2019